Internal Medicine, Medical Oncology · Atlanta, GA
NPI
1053631010
Since 2010
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
1365 Clifton Rd NE, Winship Cancer Institute
Atlanta, GA, 30322
Phone (404) 778-1900
Groups this clinician bills Medicare through
Medicare paid, 2024
$13K
191 services
Medicare patients, 2024
84
Average age 74
Drug cost, 2024
$948K
350 prescriptions
Company payments, 2025
$15K
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Olatunji B Alese was code 99215 (office e&m - established), 79 times for 61 patients. In total Olatunji B Alese billed 191 services in 10 codes, and Medicare paid $13K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-07-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 79 | 61 | $111.06 | $8,774 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 77 | 62 | $13.28 | $1,023 |
| 99205 Office E&M - New | Office | 17 | 17 | $134.08 | $2,279 |
By year: 2022 $15K for 148 services; 2023 $16K for 152 services; 2024 $13K for 191 services.
Medicare prescription drug claims, 2024
In 2024, the drug Olatunji B Alese prescribed most often to Medicare patients was Prochlorperazine Maleate, with 27 prescriptions and refills. In total Olatunji B Alese wrote 350 Medicare prescriptions that cost $948K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prochlorperazine Maleate Generic | 27 | 27 | 19 | $251 |
| Ondansetron Hcl Generic | 24 | 24 | 11 | $821 |
| Creon Lipase/Protease/Amylase | 22 | 31 | Under 11 | $69K |
| Oxycodone Hcl Generic | 21 | 21 | 15 | $141 |
| Imatinib Mesylate Generic | 20 | 20 | Under 11 | $9,371 |
| Pantoprazole Sodium Generic | 18 | 42 | Under 11 | $127 |
| Lonsurf Trifluridine/Tipiracil Hcl | 17 | 17 | Under 11 | $117K |
| Dexamethasone Generic | 15 | 15 | Under 11 | $244 |
| Lanreotide Acetate Generic | 12 | 12 | Under 11 | $99K |
Brand drugs: - claims; generic drugs: 231 claims; opioid claims: 39.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Olatunji B Alese $15K ($15K in general payments such as food, travel and fees) from 16 companies. The largest payer was Incyte Corporation with $7,281.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.